Novartis AG NVSEF
Set alert
136.10 USD -24.25 -15.12%
At close · Oct 30
136.10 Day range 136.10
120.00 52-week range 171.29
- YTD
- -1.38%
- 1 year
- +6.49%
- Open
- 136.10
- Prev close
- 160.35
- Mkt cap
- 257.04B
- Vol
- 20
- Avg vol
- 20.66K
- EPS
- 5.24
- P/E
- 25.97
More statistics
- Low
- 136.10
- High
- 136.10
- Earnings
- Oct 27, 2026
1M chart
Events in this range
- Oct 27, 2026Earnings: —; estimate 2.23; surprise —%
Signals (6)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 28, 2026 | 5 days ago |
| SMA: Bullish | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 9, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Oct 2, 2026 | 1 month ago |
Next earnings
Oct 27, 2026
Expected Oct 27, 2026. Consensus EPS estimate 2.23.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 27, 2026 | Sep 30, 2026 | 2.23 | — | — | — |
| Jul 21, 2026 | Jun 30, 2026 | 2.17 | 2.41 | +0.24 | +11.06% |
| Apr 28, 2026 | Mar 31, 2026 | 2.10 | 1.99 | -0.11 | -5.24% |
| Feb 4, 2026 | Dec 31, 2025 | 1.99 | 2.03 | +0.04 | +2.01% |
| Oct 28, 2025 | Sep 30, 2025 | 2.27 | 2.25 | -0.02 | -0.88% |
| Jul 17, 2025 | Jun 30, 2025 | 2.35 | 2.42 | +0.07 | +2.98% |
News
- Novartis: Q3 2026 Earnings Confirm 'Hold' Recommendation Based On Balanced Approach
- Novartis: The Sell-Off Creates An Attractive Entry Point
- How To Build A $50,000 Dividend Portfolio In Today's Market
- New PSMAddition data show 58% lower risk of PSA progression with Pluvicto® in metastatic hormone-sensitive prostate cancer
- Stocks That Hit 52-Week Highs On Wednesday
- Stocks That Hit 52-Week Highs On Wednesday
- Stocks That Hit 52-Week Highs On Friday
- Stocks That Hit 52-Week Highs On Friday
- Stocks That Hit 52-Week Highs On Thursday
- Stocks that Broke 52-Week Highs Tuesday
Your note
Sign in to keep a note on NVSEF — it syncs with the Stock Master app.